We are live on ! Find out more

Ardmore Shipping

ASC

Market cap $763M

18.67 USD

+0.21

1.14%

At close Updated Sep 11, 4:00 PM EDT

Pre-market

After hours

18.65

-0.02

0.11%

1 day

1.14%

5 days

3.61%

1 month

15.18%

3 months

13.98%

6 months

21.87%

Year to date

78.66%

1 year

51.3%

5 years

428.9%

10 years

157.52%

About: Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.

Employees: 940

Industrials Marine Shipping

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 36.4%

Neutral 63.6%

Negative 0%

Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys

The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins. Top GVAS dogs are projected to deliver average net gains of 36.8% by September 2027, with risk/volatility 46% below the market. Analyst targets suggest the five lowest-priced, highest-yield GVAS stocks could outperform the broader top ten by 5.12% over the next year.

Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys

Ardmore Shipping Exercises Newbuilding Options

HAMILTON, Bermuda, Aug. 27, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced it has exercised the options for a further two 40,500 dwt Handysize product/chemical tankers to be built at Wuhu Shipyard. This expands the original order to six vessels in total on similar terms, and the Company has no further options outstanding.

Ardmore Shipping Exercises Newbuilding Options

Graham Value All-Stars (GVAS) Emit 12 Bright August Buys

The August GVAS list highlights 42 large-cap value stocks, emphasizing high-yield 'dividend dogs' with strong relative value metrics. Analyst targets project 30%–55% net gains for the top ten GVAS stocks by August 2027, with an average estimated return of 40.61% and below-market volatility. Twelve of twenty-one 'safer' GVAS stocks are currently fairly priced and ideal for purchase, based on positive free cash flow yields and dividend safety.

Graham Value All-Stars (GVAS) Emit 12 Bright August Buys

Ardmore Shipping Corporation (ASC) Q2 2026 Earnings Call Transcript

Ardmore Shipping Corporation (ASC) Q2 2026 Earnings Call Transcript

Ardmore Shipping Corporation (ASC) Q2 2026 Earnings Call Transcript

Ardmore Shipping Q2 Earnings Call Highlights

Ardmore Shipping NYSE: ASC reported second-quarter adjusted earnings of $48.3 million, or $1.18 per share, as product tanker market conditions remained strong. The company declared a quarterly dividend of $0.79 per share, consistent with its policy of distributing two-thirds of adjusted earnings.

Ardmore Shipping Q2 Earnings Call Highlights

Ardmore Shipping Corporation Announces Financial Results For The Three and Six Months Ended June 30, 2026

HAMILTON, Bermuda, July 29, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore", the "Company" or "we") today announced results for the three and six months ended June 30, 2026. Highlights and Recent Activity Reported net income attributable to common stockholders of $60.5 million for the three months ended June 30, 2026, or $1.48 earnings per basic and diluted share, compared to net income attributable to common stockholders of $9.0 million, or $0.22 earnings per basic and diluted share for the three months ended June 30, 2025.

Ardmore Shipping Corporation Announces Financial Results For The Three and Six Months Ended June 30, 2026

Ardmore Shipping Announces Second Quarter 2026 Conference Call and Webcast

HAMILTON, Bermuda, July 22, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced that the Company plans to announce its second quarter earnings before the market opens on Wednesday, July 29, 2026 and will host a conference call later in the day at 10:00 a.m. Eastern Time.

Ardmore Shipping Announces Second Quarter 2026 Conference Call and Webcast

Ardmore Shipping: The War Is The Wrong Reason To Own It - Buy

Ardmore Shipping offers a compelling payout story, with Q2 spot MRs fixed at $52,100/day—nearly 5x cash breakeven—and a doubled dividend policy. ASC's Q2 earnings are largely locked in, supporting an estimated $0.83/share dividend and a projected $2.89/share full-year EPS at current run-rates. The stock is rated Buy with a $17 target, underpinned by a 12.4% yield, disciplined capital allocation, and a strong balance sheet with low leverage.

Ardmore Shipping: The War Is The Wrong Reason To Own It - Buy

July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys

July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39% for the top ten GVAS stocks by July 2027, with risk profiles generally below market volatility. The dividend dogcatcher strategy favors stocks whose $1K dividend income exceeds share price, with 36 of 54 GVAS stocks meeting this ideal condition.

July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys

Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation

CHICAGO & MILPITAS, Calif.--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) technology and genome engineering, today announced a strategic collaboration to help unlock the next generation of regenerative medicine. The collaboration will focus on evaluating ASC's iPSC and hypoimmune cell lines using Syntax Bio's proprietary Cellgorithm™ platform to advanc.

Syntax Bio and Applied StemCell Announce Strategic Collaboration to Advance Stem Cell Innovation

See News Rankings

Price charts implemented using Lightweight Charts™